Litcius/Paper detail

Pre-optimized phage therapy on secondary <i>Acinetobacter baumannii</i> infection in four critical COVID-19 patients

Nannan Wu, Jia Dai, Mingquan Guo, Jianhui Li, Xin Zhou, Feng Li, Yuan Gao, Hongping Qu, Hongzhou Lu, Jing Jin, Tao Li, Lei Shi, Qingguo Wu, Ruoming Tan, Mingli Zhu, Lan Yang, Yun Ling, Shunpeng Xing, Jianzhong Zhang, Bangxin Yao, Shuai Le, Jingmin Gu, Jinhong Qin, Jie Li, Mengjun Cheng, Demeng Tan, Linlin Li, Yiyuan Zhang, Zhaoqin Zhu, Jinfeng Cai, Zhigang Song, Xiaokui Guo, Li‐Kuang Chen, Tongyu Zhu

2021Emerging Microbes & Infections156 citationsDOIOpen Access PDF

Abstract

plaque-forming unit phages). All patients in our COVID-19-specific intensive care unit (ICU) with CRAB positive in bronchoalveolar lavage fluid or sputum samples were eligible for study inclusion if antibiotic treatment failed to eradicate their CRAB infections. While phage susceptibility testing revealed an identical profile of CRAB strains from these patients, treatment with a pre-optimized 2-phage cocktail was associated with reduced CRAB burdens. Our results suggest the potential of phages on rapid responses to secondary CRAB outbreak in COVID-19 patients.

Topics & Concepts

Phage therapyAcinetobacter baumanniiSputumVirologyOutbreakMicrobiologyAntibioticsMedicineNeonatal intensive care unitIntensive care unitBacteriophageBiologyPseudomonas aeruginosaInternal medicineBacteriaPediatricsTuberculosisGeneticsBiochemistryGeneEscherichia coliPathologyBacteriophages and microbial interactionsAntibiotic Resistance in BacteriaPneumonia and Respiratory Infections